ロード中...
Ibrutinib for B cell malignancies
Research over the role of Bruton’s agammaglobulinemia tyrosine kinase (BTK) in B-lymphocyte development, differentiation, signaling and survival has led to better understanding of the pathogenesis of B-cell malignancies. Down-regulation of BTK activity is an attractive novel strategy for treating pa...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3913970/ https://ncbi.nlm.nih.gov/pubmed/24472371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-3-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|